<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song L</submitter><funding>Discipline construction funds of Shanxi University of Chinese Medicine</funding><funding>Science and Technology Innovation Team Project of Shanxi University of Chinese Medicine</funding><funding>Science and Technology Cooperation and Exchange Special Project of Shanxi Province in 2023</funding><funding>Shanxi University of Chinese Medicine Science and Technology Innovation Capability Cultivation Plan National Natural Science Foundation Cultivation Special Project</funding><funding>Cardiovascular Special Fund Project of The National Regional Medical Center of Traditional Chinese Medicine and Affiliated Hospital of Shanxi University of Chinese Medicine</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Shanxi Science and Technology Innovation Young team Project</funding><funding>Zhang Zhongjing inheritance and Innovation Project of State Administration of Traditional Chinese Medicine</funding><pagination>161</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11965183</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(4)</volume><pubmed_abstract>Lipocalin-2 (LCN2), an acute phase protein mainly expressed in astrocytes (Ast), is closely related to the production of inflammatory cytokines following ischemic stroke. During the pathophysiological process of ischemic stroke, the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway is activated. Despite evidence suggesting some link between the two, the relationship between the JAK2/STAT3 signaling pathway and the LCN2 expression in Ast following brain ischemia is incompletely understood. Hydroxysafflower yellow A (HSYA), an active ingredient found in Carthamus tinctorius L flowers, has been demonstrated to effectively mitigate cerebral ischemia via its anti-inflammatory effect. However, whether HSYA mitigates the neuroinflammatory damage afte</pubmed_abstract><journal>Metabolic brain disease</journal><pubmed_title>Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop.</pubmed_title><pmcid>PMC11965183</pmcid><funding_grant_id>202204051001028</funding_grant_id><funding_grant_id>2024XKJS-02</funding_grant_id><funding_grant_id>82004028</funding_grant_id><funding_grant_id>2022TD2010</funding_grant_id><funding_grant_id>XGZX202115</funding_grant_id><funding_grant_id>202304041101004</funding_grant_id><funding_grant_id>GZY-KJS-2022-048-1</funding_grant_id><funding_grant_id>2020M680912</funding_grant_id><funding_grant_id>2024PY-NS-012</funding_grant_id><pubmed_authors>Song L</pubmed_authors><pubmed_authors>Hua J</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Ma C</pubmed_authors><pubmed_authors>Ma D</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Yin L</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Rong M</pubmed_authors><pubmed_authors>Xiao B</pubmed_authors><pubmed_authors>Duan Y</pubmed_authors><pubmed_authors>Yin J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop.</name><description>Lipocalin-2 (LCN2), an acute phase protein mainly expressed in astrocytes (Ast), is closely related to the production of inflammatory cytokines following ischemic stroke. During the pathophysiological process of ischemic stroke, the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway is activated. Despite evidence suggesting some link between the two, the relationship between the JAK2/STAT3 signaling pathway and the LCN2 expression in Ast following brain ischemia is incompletely understood. Hydroxysafflower yellow A (HSYA), an active ingredient found in Carthamus tinctorius L flowers, has been demonstrated to effectively mitigate cerebral ischemia via its anti-inflammatory effect. However, whether HSYA mitigates the neuroinflammatory damage afte</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-12T03:04:37.428Z</modification><creation>2025-07-12T03:04:37.428Z</creation></dates><accession>S-EPMC11965183</accession><cross_references><pubmed>40172584</pubmed><doi>10.1007/s11011-025-01581-2</doi></cross_references></HashMap>